Tff Pharmaceuticals Inc (TFFP)
$1.87
Performance
- $1.81$2.08$1.87
3.2%
Downside
Day's Volatility :12.96%
Upside
10.07%
- $0.32$11.00$1.87
82.81%
Downside
52 Weeks Volatility :97.08%
Upside
83.0%
Returns
| Period | Tff Pharmaceuticals Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | -4.1% | 4.9% | 0.0% |
6 Months | -56.1% | 5.8% | 0.0% |
1 Year | -77.4% | 16.5% | 0.0% |
3 Years | -98.95% | 20.3% | -20.1% |
Highlights
Market Capitalization | 6.5M |
Book Value | $1.81 |
Earnings Per Share (EPS) | -6.88 |
Wall Street Target Price | 30.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -609.42% |
Return On Assets TTM | -105.91% |
Return On Equity TTM | -213.51% |
Revenue TTM | 1.2M |
Revenue Per Share TTM | 0.47 |
Quarterly Revenue Growth YOY | 95.1% |
Gross Profit TTM | -21.2M |
EBITDA | -19.0M |
Diluted Eps TTM | -6.88 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.28 |
EPS Estimate Next Year | -3.77 |
EPS Estimate Current Quarter | -1.7 |
EPS Estimate Next Quarter | -1.35 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 1504.28%
Technicals Summary
Sell
Neutral
Buy
Tff Pharmaceuticals Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Tff Pharmaceuticals Inc | 4.47% | -56.1% | -77.4% | -98.95% | -98.52% |
 Regeneron Pharmaceuticals, Inc. | -10.33% | 8.11% | 21.28% | 85.63% | 257.49% |
 Novo Nordisk A/s | -12.25% | -9.71% | 24.92% | 138.38% | 343.21% |
 Alnylam Pharmaceuticals, Inc. | 9.22% | 72.73% | 52.35% | 34.04% | 250.13% |
 Vertex Pharmaceuticals Incorporated | -3.09% | 12.2% | 25.77% | 150.7% | 163.62% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Tff Pharmaceuticals Inc | NA | NA | NA | -4.28 | -2.14 | -1.06 | NA | 1.81 |
Regeneron Pharmaceuticals, Inc. | 27.55 | 27.55 | 1.42 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 38.7 | 38.7 | 1.75 | 3.41 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.49 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.55 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Tff Pharmaceuticals Inc | Buy | $6.5M | -98.52% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $114.7B | 257.49% | 27.55 | 32.04% |
Novo Nordisk A/s | Buy | $518.0B | 343.21% | 38.7 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.9B | 250.13% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $119.3B | 163.62% | 32.84 | -4.74% |
Insights on Tff Pharmaceuticals Inc
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 52.3% return, outperforming this stock by 129.7%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 34.0% return, outperforming this stock by 132.9%
Institutional Holdings
Carlson Capital LP
8.47%Armistice Capital, LLC
5.36%Westside Investment Management, Inc.
1.46%DRW Securities, LLC
1.15%Geode Capital Management, LLC
0.63%Renaissance Technologies Corp
0.43%
Company Information
tff pharmaceuticals, inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented thin film freezing (tff) technology. our patented thin film freezing (tff) platform makes it possible to turn more molecules into inhalable therapies. this novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. tff pharmaceuticals has two lead drug candidates: voriconazole inhalation powder and tac-lac inhalation powder. the company plans to add to this pipeline by collaborating with large pharmaceutical partners. the tff platform is protected by 42 patents issued or pending in the us and internationally.
Organization | Tff Pharmaceuticals Inc |
Employees | 19 |
CEO | Dr. Harlan F. Weisman |
Industry | Health Technology |
Discover More
Eagle Pharmaceuticals Inc.
$1.87
+0.0%
Graniteshares 2x Long Baba Daily Etf
$1.87
+0.0%
Mingteng International Corp Inc
$1.87
+0.0%
Direct Digital Holdings Inc
$1.87
+0.0%
Dt Cloud Star Acquisition Corporation Right
$1.87
+0.0%
Precipio Inc
$1.87
+0.0%
Venus Concept Inc
$1.87
+0.0%
Fidelity Msci Materials Etf
$1.87
+0.0%
Inspire International Etf
$1.87
+0.0%